Delivery Order SPE2DB25D3404-SPE2DB25FUNFE
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has a ceiling value of $1,375.62 and is a firm fixed-price delivery order with a completion date of June 30, 2025. The contract is not set aside for any specific business type....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $3,866.40 and a completion date of June 10, 2025. This delivery order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,242.88 and a period of performance through May 15, 2025. The contract is not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.64, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,618.58, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a firm fixed price ceiling value of $1,616.49 and a completion date of July 2, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Omnipod 5 DEXG7G6 Pods (Gen 5), a diabetes medical device, with a ceiling value of $54,065.59. The contract is a firm-fixed-price, non-set-aside award with a period of performance through April 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract has a ceiling value of $6,653.87 and a period of performance through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a ceiling value of $9,746.97 and a period of performance through April 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, medical devices used in the management of diabetes. The contract has a firm fixed-price, non-set-aside structure with a ceiling value of $22,672.82 and a period of performance through June 18, 2025. AmerisourceBergen Drug Corp is a significant vendor for the...